CDKN2A and cancer: Further experiments are therefore necessary to determine if senescence is indeed a general adaptive pathway to chemotherapy, if this concerns only a specific subset of cancer cells and how this relies on the integrity of p53, p21, and p16 signaling or on specific oncogenic pathways.